Immatics Events Q1 2019

| News

Immatics, a leading company in the field of cancer immunotherapy, will be attending the industry conferences and meetings listed below. You can also download the complete list here: Immatics Events Q1 2019. 

To arrange meetings with Immatics at any of the events, please contact info@immatics.com

 

JP Morgan

January 7th-10th, San Francisco, USA

  

18th Annual PepTalk: The Protein Science Week

January 14th-18th, San Diego, USA

  

LSX World Congress

February 5th-6th, London, UK

  

Cell Gene Therapy Innovation Summit 2019

February 6th-7th, Berlin, Germany

  

Engineered Immune Cells in Cancer Immunotherapy: From Discovery to Off-the shelf Development

February 15th-16th, Doha, Qatar

  

CAR-TCR Summit Europe

February 26th-28th, London, UK

  

Antibody & Protein Therapeutics Asia

February 26th-28th, Tokyo, Japan

  

Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit

March 10th-14th, Whistler, Canada

  

26th International Molecular Med TRI-CON

March 10th-15th, San Francisco, USA

 

Cancer Immunotherapy: Executive Summit Emerging Immuno-Oncology Targets, Modalities, and Combinations

March 11th-13th, San Francisco, USA

  

BioProcess International US West

March 11th-14th, Santa Clara, USA

  

Cambridge Healthtech Institute’s 2nd Annual Adoptive Cell-Based Cancer Immunotherapy

March 14th-15th, San Francisco, USA

  

Bioprocessing Summit Europe

March 19th-21st, Lisbon, Portugal

  

BioEurope Spring

March 25th-27th, Vienna, Austria

  

AACR Annual Meeting 2019

March 29th – April 3rd, Atlanta, USA

 

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back